loading
Coeptis Therapeutics Holdings Inc stock is traded at $9.31, with a volume of 32,538. It is down -5.86% in the last 24 hours and down -21.83% over the past month. Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
See More
Previous Close:
$9.89
Open:
$9.4
24h Volume:
32,538
Relative Volume:
0.09
Market Cap:
$30.18M
Revenue:
-
Net Income/Loss:
$-11.62M
P/E Ratio:
-1.6625
EPS:
-5.6
Net Cash Flow:
$-6.91M
1W Performance:
-29.31%
1M Performance:
-21.83%
6M Performance:
+127.07%
1Y Performance:
-5.27%
1-Day Range:
Value
$9.31
$9.7514
1-Week Range:
Value
$9.27
$13.50
52-Week Range:
Value
$2.31
$13.70

Coeptis Therapeutics Holdings Inc Stock (COEP) Company Profile

Name
Name
Coeptis Therapeutics Holdings Inc
Name
Phone
724-934-6467
Name
Address
105 BRADFORD ROAD, SUITE 420, WEXFORD
Name
Employee
7
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
COEP's Discussions on Twitter

Compare COEP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
 icon
COEP
COEPTIS THERAPEUTICS INC
6.99 2.70M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.1935 408.35M 2.07B -1.42B -1.37B -0.6765
 icon
GOODO
Gladstone Commercial Corporation
20.50 372.90M 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
0.4399 278.60M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
2.79 120.14M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
4.0439 52.60M 0 0 0 0.00

Coeptis Therapeutics Holdings Inc Stock (COEP) Latest News

pulisher
Feb 23, 2025

Trading (COEP) With Integrated Risk Controls - Stock Traders Daily

Feb 23, 2025
pulisher
Feb 20, 2025

Stock market today: OSR Holdings -34.43%, Coeptis Therapeutics Holdings -29.77% among biggest losers in early trading - Business Upturn

Feb 20, 2025
pulisher
Feb 20, 2025

Coeptis’ NexGenAI Affiliates Network & MarketLeverage partner in marketing - TipRanks

Feb 20, 2025
pulisher
Feb 20, 2025

Coeptis Therapeutics’ NexGenAI partners with Arketyp Valu - TipRanks

Feb 20, 2025
pulisher
Feb 20, 2025

COEPTIS' NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus Network - The Manila Times

Feb 20, 2025
pulisher
Feb 20, 2025

How NexGenAI's Blockchain Partnership Could Transform Digital Marketing Forever - StockTitan

Feb 20, 2025
pulisher
Feb 20, 2025

COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing - The Manila Times

Feb 20, 2025
pulisher
Feb 20, 2025

Coeptis Nexgenai Affiliates Network & Marketleverage Announce Partnership -February 20, 2025 at 07:29 am EST - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Coeptis Partners with MarketLeverage to Integrate AI in Affiliate Marketing Strategies - Nasdaq

Feb 20, 2025
pulisher
Feb 20, 2025

How This AI Marketing Partnership Could Tap Into a $106B Market Opportunity - StockTitan

Feb 20, 2025
pulisher
Feb 20, 2025

COEPTIS NexGenAI Affiliates Network & MarketLeverage Strategically Partner - Martechcube

Feb 20, 2025
pulisher
Feb 19, 2025

Coeptis, MarketLeverage partner for AI-driven marketing By Investing.com - Investing.com South Africa

Feb 19, 2025
pulisher
Feb 19, 2025

Coeptis, MarketLeverage partner for AI-driven marketing - Investing.com

Feb 19, 2025
pulisher
Feb 14, 2025

Coeptis launches venture group for AI and automation startups - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

Coeptis launches venture group for AI and automation startups By Investing.com - Investing.com Nigeria

Feb 14, 2025
pulisher
Feb 13, 2025

Coeptis Therapeutics (COEP): Launching AI-Focused Venture Arm to Fuel Innovation - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

How Coeptis Therapeutics is Harnessing AI to Shift the Biopharma Paradigm - Bit Perfect Solutions

Feb 13, 2025
pulisher
Feb 13, 2025

Is Coeptis Therapeutics the Dark Horse in AI Innovation? - Smartphone Magazine

Feb 13, 2025
pulisher
Feb 13, 2025

Top 10 Must-See AI News And Ratings For Investors - Insider Monkey

Feb 13, 2025
pulisher
Feb 13, 2025

COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups - The Manila Times

Feb 13, 2025
pulisher
Feb 13, 2025

Coeptis, Inc. Launches COEP Venture Group to Invest in AI and Automation Startups - Nasdaq

Feb 13, 2025
pulisher
Feb 13, 2025

COEPTIS Announces The Launch Of COEP Venture Group To Invest In AI, RPA, And AI Agent Startups - Marketscreener.com

Feb 13, 2025
pulisher
Feb 13, 2025

Major AI Investment Initiative: COEPTIS Creates New Venture Arm for Next-Gen Tech Startups - StockTitan

Feb 13, 2025
pulisher
Feb 13, 2025

How the (COEP) price action is used to our Advantage - Stock Traders Daily

Feb 13, 2025
pulisher
Feb 10, 2025

Coeptis Therapeutics Holdings Inc - Stockhouse Publishing

Feb 10, 2025
pulisher
Feb 10, 2025

COEPTIS raises additional $5.7M in funding to accelerate company innovation, automation - Pennsylvania Business Report

Feb 10, 2025
pulisher
Feb 08, 2025

Coeptis Therapeutics Holdings, Inc. (COEP) Raises $10M to Advance AI-Driven Cell Therapy Innovations - Insider Monkey

Feb 08, 2025
pulisher
Feb 06, 2025

10 AI News Updates Making Waves on Wall Street - Insider Monkey

Feb 06, 2025
pulisher
Feb 06, 2025

Strategic $10M Funding Positions Coeptis for AI-Powered Biotech Revolution - StockTitan

Feb 06, 2025
pulisher
Jan 31, 2025

Coeptis Therapeutics Holdings, Inc. (COEP): Pioneering AI-Powered Marketing for Healthcare Innovation - Insider Monkey

Jan 31, 2025
pulisher
Jan 31, 2025

10 AI News and Ratings Investors Should Take a Look At - Insider Monkey

Jan 31, 2025
pulisher
Jan 30, 2025

Local biopharmaceutical company rebrands, embracing AI and blockchain technologiesPittsburgh Business Times - The Business Journals

Jan 30, 2025
pulisher
Jan 30, 2025

Coeptis Therapeutics shifts focus with rebrand and AI tech - MSN

Jan 30, 2025
pulisher
Jan 30, 2025

Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation - Citizentribune

Jan 30, 2025
pulisher
Jan 30, 2025

Coeptis Therapeutics shifts focus with rebrand and AI tech By Investing.com - Investing.com Australia

Jan 30, 2025
pulisher
Jan 30, 2025

Pharma Company Makes Bold AI Pivot: Inside Coeptis's Tech Transformation - StockTitan

Jan 30, 2025
pulisher
Jan 27, 2025

Coeptis Therapeutics Holdings expands technological initiatives - Pennsylvania Business Report

Jan 27, 2025
pulisher
Jan 27, 2025

Coeptis Therapeutics Holdings, Inc. announced that it has received $1.1 million in funding from Yorkville Advisors Global LP - Marketscreener.com

Jan 27, 2025
pulisher
Jan 24, 2025

Coeptis Therapeutics secures $1.1 million convertible note By Investing.com - Investing.com Australia

Jan 24, 2025
pulisher
Jan 24, 2025

Coeptis Therapeutics secures $1.1 million convertible note - Investing.com India

Jan 24, 2025
pulisher
Jan 23, 2025

Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation - Marketscreener.com

Jan 23, 2025
pulisher
Jan 23, 2025

Coeptis Boosts AI Capabilities, Explores Blockchain - Contract Pharma

Jan 23, 2025
pulisher
Jan 22, 2025

Coeptis Therapeutics Regains Nasdaq Compliance, Secures Exchange Listing Status - StockTitan

Jan 22, 2025
pulisher
Jan 17, 2025

Coeptis Therapeutics (Nasdaq: COEP) Emerges as a Biopharma Innovator Leveraging AI-Driven Marketing - Barchart

Jan 17, 2025
pulisher
Jan 15, 2025

Midday Market Movers: Biggest Stock Declines of the Day – Market - HPBL

Jan 15, 2025
pulisher
Jan 07, 2025

Coeptis announces $1.7 million from new AI marketing deals - Investing.com

Jan 07, 2025
pulisher
Jan 07, 2025

Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform - PR Newswire

Jan 07, 2025

Coeptis Therapeutics Holdings Inc Stock (COEP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):